» Articles » PMID: 17650446

Demonstration of Changes in Plasma Cell Subsets in Multiple Myeloma

Overview
Journal Haematologica
Specialty Hematology
Date 2007 Jul 26
PMID 17650446
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Increases in free light chain (FLC) production are associated with disease progression in multiple myeloma (MM). Using a double immunofluorescence staining method to produce a differential count of plasma cells in bone marrow, single populations were demonstrated, containing intact monoclonal immunoglobulins (M-Igs) in 74% and FLCs only in 8% of cases. However, 18% contained a mixture of both cell populations. Progression from cells making intact M-Ig to cells restricted to FLC only production occurred in individual cases during the course of their disease. The presence of FLC only cells was associated with shortened survival.

Citing Articles

Single-Cell RNA Sequencing before and after Light Chain Escape Reveals Intrapatient Multiple Myeloma Subpopulations with Divergent Osteolytic Gene Expression.

Ohlstrom D, Walker Z, Pandey A, Davis L, Engel K, Pan Z Cancer Res Commun. 2024; 5(1):106-118.

PMID: 39699274 PMC: 11737298. DOI: 10.1158/2767-9764.CRC-24-0170.


Clinical characteristics and prognostic significance of immunoglobulin isotype switch in patients with multiple myeloma.

Lu M, Chu B, Wang Y, Shi L, Gao S, Fang L Cancer Pathog Ther. 2024; 1(2):149-153.

PMID: 38328401 PMC: 10846323. DOI: 10.1016/j.cpt.2022.11.002.


Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma.

Tacchetti P, Rocchi S, Zamagni E, Barbato S, Rizzello I, De Cicco G Am J Hematol. 2022; 97(12):1607-1615.

PMID: 36198076 PMC: 9828555. DOI: 10.1002/ajh.26747.


Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma.

Ovejero S, Moreaux J Explor Target Antitumor Ther. 2022; 2(1):65-106.

PMID: 36046090 PMC: 9400753. DOI: 10.37349/etat.2021.00034.


Light Chain Escape in 3 Cases: Evidence of Intraclonal Heterogeneity in Multiple Myeloma from a Single Institution in Poland.

Kraj M, Kruk B, Endean K, Warzocha K, Budziszewska K, Dabrowska M Case Rep Hematol. 2016; 2015:809840.

PMID: 26881153 PMC: 4736005. DOI: 10.1155/2015/809840.